Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
November 2019 Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis Simón Serrano. S, Grönberg. A, Longato. L, Rombouts. K, Kuo. J, Gregory. M, Moss. S, Elmér. E, Mazza. G, Gallay. P, Pinzani. M, Hansson. M.J, Massoumi. R. Cells. 8(11):1409.